Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. [electronic resource]
Producer: 20121120Description: 1256-66 p. digitalISSN:- 1524-4539
- Animals
- Antibodies, Monoclonal -- immunology
- Antibodies, Neutralizing -- immunology
- Antigen-Antibody Complex -- immunology
- Apolipoproteins E -- genetics
- Atherosclerosis -- drug therapy
- Biomarkers -- metabolism
- CD4 Antigens -- metabolism
- Cell Division -- drug effects
- Dietary Fats -- pharmacology
- Disease Models, Animal
- Disease Progression
- Dose-Response Relationship, Immunologic
- Forkhead Transcription Factors -- metabolism
- Interleukin-2 -- immunology
- Interleukin-2 Receptor alpha Subunit -- metabolism
- Male
- Mice
- Mice, Mutant Strains
- T-Lymphocytes, Regulatory -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.